| The Antimicrobial, Antioxidant, and Anticancer Activity of Greenly Synthesized Selenium and Zinc Composite Nanoparticles Using Ephedra aphylla Extract MM El-Zayat, MM Eraqi, H Alrefai, AY El-Khateeb, MA Ibrahim, ... Biomolecules 11 (3), 470, 2021 | 55 | 2021 |
| Genetic mutations associated with lung cancer metastasis to the brain HM Aljohani, M Aittaleb, JM Furgason, P Amaya, A Deeb, JJ Chalmers, ... Mutagenesis 33 (2), 137-145, 2018 | 42 | 2018 |
| ROS1 amplification mediates resistance to gefitinib in glioblastoma cells H Aljohani, RF Koncar, A Zarzour, BS Park, SH Lee, EM Bahassi Oncotarget 6 (24), 20388, 2015 | 21 | 2015 |
| Shikonin Alleviates Gentamicin-Induced Renal Injury in Rats by Targeting Renal Endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt Cascades MF Balaha, AA Alamer, AA Eisa, HM Aljohani Antibiotics 12 (5), 826, 2023 | 8 | 2023 |
| Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced … N Abdel-Karim, O Gaber, HM Aljohani, I Eldessouki, EM Bahassi, J Morris Asian Pacific journal of cancer prevention: APJCP 20 (12), 3789, 2019 | 7 | 2019 |
| Neuroprotective Effects of Nano-Curcumin against Cypermethrin Associated Oxidative Stress and Up-Regulation of Apoptotic and Inflammatory Gene Expression in Rat Brains M Ashafaq, S Hussain, S Alshahrani, R Siddiqui, MI Alam, ... Antioxidants 12 (3), 644, 2023 | 3 | 2023 |
| Targeting Tyrosine Kinase Drug Resistance Mechanisms and Metastatic Pathways in Brain Tumors HM Aljohani University of Cincinnati, 2020 | | 2020 |
| The role of Nrf2-Keap1 pathway in the survival of circulating metastatic cancer cells HM Aljohani, JM Furgason, P Amaya, A Deeb, JJ Chalmers, EM Bahassi Cancer Research 78 (13_Supplement), 83-83, 2018 | | 2018 |
| Preclinical evaluation of a new ROS1 inhibitor to overcome resistance to EGFR therapy in glioblastoma HM Aljohani, EM Bahassi The FASEB Journal 32, 674.27-674.27, 2018 | | 2018 |
| Abstract C134: Alternative pathways associated with resistance to tyrosine kinase inhibitors in glioblastoma HM Aljohani, RF Koncar, A Zarzour, B Sun Park, SH Lee, EM Bahassi Molecular Cancer Therapeutics 14 (12_Supplement_2), C134-C134, 2015 | | 2015 |
| Signaling Pathways Associated with Gefitinib Resistance in Glioblastoma Multiforme (GBM) HM Aljohani University of Cincinnati, 2014 | | 2014 |
